FDA Inspection 1252468 — Gulf Coast Regional Blood Center at Cypress Fairbanks

Gulf Coast Regional Blood Center at Cypress Fairbanks — FEI 3001238018

The FDA completed an inspection of Gulf Coast Regional Blood Center at Cypress Fairbanks on October 11, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 11, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)